Prothena Corp Public (PRTA) Current Deferred Revenue (2021 - 2026)

Prothena Corp Public's Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• On a quarterly basis, Current Deferred Revenue fell 82.84% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 82.84% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 69.9% from the prior year.
• Current Deferred Revenue eased to $1.6 million in Q1 2026 per PRTA's latest filing, from $2.7 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $109.5 million in Q1 2022 and bottomed at $316000.0 in Q3 2023.
• The 5-year median for Current Deferred Revenue is $9.4 million (2023), against an average of $28.9 million.
• Across the five-year window, Current Deferred Revenue plunged 96.73% in 2023 and jumped 2684.81% in 2024, its largest moves.
• Year by year, Current Deferred Revenue stood at $11.4 million in 2022, then slumped by 97.24% to $316000.0 in 2023, then soared by 2700.63% to $8.8 million in 2024, then plunged by 69.9% to $2.7 million in 2025, then plunged by 38.81% to $1.6 million in 2026.
• Per Business Quant, the three latest PRTA Current Deferred Revenue figures stand at $1.6 million (Q1 2026), $2.7 million (Q4 2025), and $2.7 million (Q3 2025).